Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
adultlymphomamultiple-myeloma
hematologic malignancy, bone marrow transplant rejection, acute myeloid leukemia (aml), myelodysplastic syndromes (mds), acute lymphoblastic leukemia (all), adult, multiple myeloma, aplastic anemia, lymphoma, non hodgkin lymphoma, hodgkin lymphoma, chronic myeloid leukemia, myelofibrosis
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 877911
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.